| Citation: |
YANG Xi, CHU Yaojuan, CHEN Juanjuan, YANG Ting, LIU Chong, ZHANG Rui, DU Shuzhang. Visual Analysis and Focused Areas of Immunotherapy for Liver Cancer Based on Literature Data[J]. Cancer Research on Prevention and Treatment, 2021, 48(10): 963-969. DOI: 10.3971/j.issn.1000-8578.2021.21.0541
|
To compare the research status and hotspots of immunotherapy for liver cancer at home and abroad.
Papers about immunotherapy for liver cancer published from the establishment to 2019 were searched in PubMed database and Chinese database. Information were extracted and sorted by BICOMB-2 software, and then we created the word matrix and co-occurrence matrix of high-frequency subject headings. The cluster analysis of subject headings was conducted by gCLUTO 1.0. NetDraw 2.089 was used to draw social network diagrams, UCINET 6.212 was used to conduct the centrality analysis.
There were 2 081 foreign literatures and 901 Chinese literatures, involving 655 foreign periodicals and 275 Chinese periodicals. Four themes of immunotherapy for liver cancer were determined: the correlation between the immune inoculation of hepatitis B patients and the occurrence of liver cancer, the study between dendritic cells and immunotherapy for liver cancer, the study of the combination of radiotherapy and immunotherapy on liver cancer, and related research of natural killer cells and liver cancer immunotherapy.
The number of researches on immunotherapy for liver cancer have shown an increasing trend year by year. We can learn from the international research status and hotspots to create a new way for liver cancer treatment.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Forner A, Reig M, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2018, 391(10127): 1301-1314. doi: 10.1016/S0140-6736(18)30010-2
|
| [2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality world-wide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
| [3] |
Iñarrairaegui M, Melero I, Sangro B. Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes[J]. Clin Cancer Res, 2018, 24(7): 1518-1524. doi: 10.1158/1078-0432.CCR-17-0289
|
| [4] |
沈宗毅, 李卯晨, 白素杭, 等. 肝癌免疫治疗的研究进展[J]. 生物工程学报, 2019, 35(12): 2326-2338. https://www.cnki.com.cn/Article/CJFDTOTAL-SHWU201912011.htm
Shen ZY, Li MC, Bai SH, et al. Progress in immunotherapy for hepatocellular carcinoma[J]. Sheng Wu Gong Cheng Xue Bao, 2019, 35(12): 2326-2338. https://www.cnki.com.cn/Article/CJFDTOTAL-SHWU201912011.htm
|
| [5] |
崔雷, 刘伟, 闫雷, 等. 文献数据库中书目信息共现挖掘系统的开发[J]. 现代图书情报技术, 2008, 8: 70-75. https://www.cnki.com.cn/Article/CJFDTOTAL-XDTQ200808015.htm
Cui X, Liu W, Yan L, et al. Development of a Text Mining System Based on the Co-occurrence of Bibliographic Items in Literature Databases[J]. Xian Dai Tu Shu Qing Bao Ji Shu, 2008, 8: 70-75. https://www.cnki.com.cn/Article/CJFDTOTAL-XDTQ200808015.htm
|
| [6] |
刘珏, 李维, 王永清. 妊娠期高血压疾病国际研究热点的文献计量分析[J]. 中国妇幼健康研究, 2017, 28(3): 262-266. doi: 10.3969/j.issn.1673-5293.2017.03.014
Liu J, Li W, Wang YQ. Bibliometric study on international research hotspots for hypertensive disorders of pregnancy[J]. Zhong Guo Fu You Jian Kang Yan Jiu, 2017, 28(3): 262-266. doi: 10.3969/j.issn.1673-5293.2017.03.014
|
| [7] |
刘甲学, 冯畅. 基于共词分析的国内信息资源管理研究热点可视化分析[J]. 情报科学, 2016, 34(11): 173-176. https://www.cnki.com.cn/Article/CJFDTOTAL-QBKX201611033.htm
Liu JX, Feng C. Visualization Analysis on the Hot Topics of Information Resource Management Based on Co-word Analysis in China[J]. Qing Bao Ke Xue, 2016, 34(11): 173-176. https://www.cnki.com.cn/Article/CJFDTOTAL-QBKX201611033.htm
|
| [8] |
Kao JH. Hepatitis B vaccination and prevention of hepatocellular carcinoma[J]. Best Pract Res Clin Gastroenterol, 2015, 29(6): 907-917. doi: 10.1016/j.bpg.2015.09.011
|
| [9] |
Yu M, Li Z. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches[J]. Front Med, 2017, 11(4): 509-521. doi: 10.1007/s11684-017-0546-3
|
| [10] |
冯钟煦, 刘剑勇, 赵荫农, 等. H22细胞全细胞抗原负载的树突状细胞激活肿瘤浸润性淋巴细胞抗小鼠肝癌的实验[J]. 肿瘤防治研究, 2012, 39(10): 1179-1182. doi: 10.3971/j.issn.1000-8578.2012.10.005
Feng ZX, Liu JY, Zhao YN, et al. Anti-mouse Hepatoma Effect of Tumor-infiltrating Lymphocyte Stimulated by DCs Pulsed with H22 Full-cell Antigen[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39(10): 1179-1182. doi: 10.3971/j.issn.1000-8578.2012.10.005
|
| [11] |
Su H, Li B, Zheng L, et al. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma[J]. Oncotarget, 2016, 7(30): 48401-48411. doi: 10.18632/oncotarget.10269
|
| [12] |
Cahan B, Leong L, Wagman L, et al. Phase Ⅰ/Ⅱ Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma[J]. Cancer Biother Radiopharm, 2017, 32(7): 258-265. doi: 10.1089/cbr.2017.2223
|
| [13] |
Keane FK, Hong TS, Zhu AX. Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy[J]. Semin Radiat Oncol, 2018, 28(4): 332-341. doi: 10.1016/j.semradonc.2018.06.006
|
Figures(6) / Tables(7)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: